Print Page   |   Sign In
News & Press: Members in the News

Kalin Named Editor of American Journal of Psychiatry

Wednesday, April 11, 2018  
Share |

The American Psychiatric Association (APA) announced today that Ned H. Kalin, M.D., will assume the role of Editor in Chief of the American Journal of Psychiatry (AJP) beginning Jan. 1, 2019.

The American Journal of Psychiatry is the premier journal of the APA and is the most widely read psychiatric journal in the world.

Kalin, who is Hedberg Professor and Chair of the Department of Psychiatry at the University of Wisconsin School of Medicine and Public Health, is among the most accomplished biological psychiatrists, working to understand the brain mechanisms underlying mental disorders. 

Kalin also serves as the Director of the HealthEmotions Research Institute and Director of the Lane Neuroimaging Laboratory, both at the University of Wisconsin School of Medicine and Public Health.  He is a member of the National Academy of Medicine (2015) and a member of the Editorial Board of Personalized Medicine in Psychiatry (2016). Kalin is principal investigator on several ongoing research projects funded by the National Institute of Mental Health. He is a Distinguished Fellow of the APA and has served on the APA Council on Research (2015-2018).

“We anticipate the journal, under Dr. Kalin’s leadership, to lead the field of psychiatry and reflect where the field is headed in research and treatment,” said APA CEO and Medical Director Saul Levin, M.D., M.P.A. “We are very excited about Dr. Kalin’s appointment to head the AJP.”

“While I emphasize the importance of integrating a translational behavioral and neuroscience aspect to AJP, I am highly invested in the clinical components of our field and the Journal,” Kalin said.  “I believe that the strength of AJP lies in combining its clinical focus, which includes case reports, clinical research and reviews, with clinical commentary. Adding translational neuroscience to the clinical strengths of the journal is an exciting opportunity to blend scientific advances with clinical applications.”         

Kalin will replace current editor Robert Freedman, M.D., when his third and final term ends on Dec. 31, 2018.